PLA2G4D and esophageal squamous cell carcinoma: TRPM7, MAPK11, and PRKCQ were identified as “protective” factors for ESCC patients, while PLA2G4D, RIPK3, CALML3 and MAPK9 were identified as “risk” factors (Figure 1E).